Genome‐Wide Expression Profiling of Human Hepatocellular Carcinoma

Budhu, Anuradha; Wang, Xin Wei

doi:10.1002/9780470747919.ch61

Cited by 1 publication

(1 citation statement)

References 113 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These investigations provided huge amounts of the information showing global alterations of gene expression in HCC and alterations of certain signaling pathways. Several recent reviews have summarized the studies of the gene expression signatures [1-4]; therefore, our review mentions a small part of these findings which is related to the focus of the current review. A significant portion of studies of liver cancer was performed using well established chemical carcinogenesis mediated by diethylnitrosamine/phenobarbital (DEN/PB) [5], mouse models of hepatocellular carcinoma [6, 7] and HCC samples from patients with liver cancer [1].…”

Section: Introductionmentioning

confidence: 99%

Intracellular signaling and hepatocellular carcinoma

Iakova

Timchenko²,

Timchenko³

2011

Seminars in Cancer Biology

View full text Add to dashboard Cite

Liver cancer is the fifth most common cancer and the third most common cause of cancer related death in the world. The recent development of new techniques for the investigations of global change in the gene expression, signaling pathways and wide genome binding has provided novel information for the mechanisms underlying liver cancer progression. Although these studies identified gene expression signatures in hepatocelluar carcinoma, the early steps of the development of hepatocellular carcinomas (HCC) are not well understood. The development of HCC is a multistep process which includes the progressive alterations of gene expression leading to the increased proliferation and to liver cancer. This review summarizes recent progress in the identification of the key steps of the development of HCC with the focus on early events of carcinogenesis and on the role of translational and epigenetic alterations in the development of HCC. Quiescent stage of the liver is supported by several tumor suppressor proteins including p53, Rb and C/EBPα. Studies with chemical models of liver carcinogenesis and with human HCC have shown that the elevation of gankyrin is responsible for the elimination of these three proteins at early steps of carcinogenesis. Later stages of progression of the liver cancer are associated with alterations in many signaling pathways including translation which leads to epigenetic silencing/activation of many genes. Particularly, recent reports suggest a critical role of histone deacetylase 1, HDAC1, in the development of HCC through the interactions with transcription factors such as C/EBP family proteins.

show abstract